Clinical effectiveness

Autor: A. Abdullah, A. N. Omar, R. Mulcahy, A. Clapp, E. Tullo, D. Carrick-Sen, J. Newton, B. Hirst, V. Krishnaswami, A. Foster, D. Vahidassr, T. Chavan, A. Matthew, C. P. Trolan, C. Steel, G. Ellis, D. J. Ahearn, K. Lotha, P. Shukla, D. R. Bourne, A. Mathur, K. Musarrat, A. Patel, G. Nicholson, E. Nelson, S. McNicholl, H. McKee, J. Cuthbertson, E. Lunt, S. Lee, J. Okeke, J. Daniel, A. Naseem, S. Ramakrishna, I. Singh, J. R. Barker, A. J. Weatherburn, L. Thornton, C. Holly, J. Jones, A. Varanasi, A. Verma, J. A. H. Foster, C. Carmichael, C. Cawston, S. Homewood, M. Leitch, J. Martin, J. McDicken, J. Lonnen, J. Bishop-Miller, L. C. Beishon, J. K. Harrison, S. P. Conroy, J. R. F. Gladman, J. Sim, F. Byrne, J. Currie, S. Ollman, S. Brown, M. Wilkinson, A. Manoj, F. Hussain, A. Druhan, M. Thompson, J. Tsang, J. Soh, C. Offiah, T. Coughlan, P. O'Brien, D. J. H. McCabe, S. Murphy, J. McManus, D. O'Neill, D. R. Collins, K. Warburton, N. Maini, A.- L. Cunnington, P. Mathew, K. Hoyles, M. Lythgoe, H. Brewer, J. Western-Price, K. Colquhoun, K. Ramdoo, J. Bowen, O. T. Dale, R. Corbridge, A. Chatterjee, M. A. Gosney, L. Richardson, L. Daunt, A. Ali, R. Harwood, L. A. Beveridge, J. Harper, L. D. Williamson, J. S. T. Bowen, L. Wentworth, K. Wardle, J. Ruddlesdin, S. Baht, N. Roberts, O. Corrado, J. Morell, P. Baker, N. Whiller, I. Wilkinson, M. Barber, A. Maclean, J. Frieslick, A. Reoch, A. McSorley, A. Crawford, S. Sarup, A. Niruban, J. D. Edwards, S. J. Bailey, H. M. May, P. Mathieson, H. Jones, R. Ray, R. Prettyman, R. Gibson, A. Heaney, K. Hull, B. Manku, S. Bellary, S. Ninan, G. Chhokar, D. Sweeney, W. Nivatongs, S. Y. Wong, T. Aung, T. Kalsi, G. Babic-Illman, D. Harari, M. Aljaizani, A. T. Pattison, J. Fox, S. Reilly, V. Chauhan, M. Azad, J. Youde, J. Lagan, H. Cooper, D. Komrower, V. Price, C. B. von Stempel, B. Gilbert, N. Bouwmeester, H. W. Jones, T. Win, C. Weekes, R. Hodgkinson, S. Walker, K. Le Ball, Z. N. Muir

Publikováno v: Age and Ageing. 42:iii1-iii11

Introduction: Although older individuals are more prone to hypoglycaemia, it is not known if they have sufficient understanding of the risks of hypoglycaemia or the factors that predispose to it. We evaluated the effectiveness of hypoglycaemia educat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9a68b544164bb135569a85fed897cba7
https://doi.org/10.1093/ageing/aft096

P11 Tyrosine kinase inhibitor use in pulmonary adenocarcinoma

Autor: D Komrower, M Murthy, G Jones, M.J. Walshaw, N Hunt, Martin Ledson

Publikováno v: Thorax. 68:A79.2-A79

Introduction Personalised treatments are becoming increasingly important in medicine, and the use of tyrosine kinase inhibitors (TKI) in the management of the subset of patients with pulmonary adenocarcinomas which express a mutation in the epidermal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4fc040c26543fe5ce28cf3abe18f198d
https://doi.org/10.1136/thoraxjnl-2013-204457.161

S110 Experience with suspected cancer referrals from the UK lung screen trial

Autor: M.J. Walshaw, Martin Ledson, John A Holemans, D Komrower, John K. Field, M Murthy, N Hunt, G Jones

Publikováno v: Thorax. 68:A57.3-A58

Introduction Early diagnosis of lung cancer improves survival and strategies to facilitate this include screening high risk populations. The ongoing UK Lung Screen Trial (UKLS) is investigating this with low-dose CT scans, and positive screens are re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::439e5cb6e36402f2ea6e09a9653765af
https://doi.org/10.1136/thoraxjnl-2013-204457.117

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.